- Targeted Delivery of Anti-Inflammatory Agents to Tumors
[作者：Coimbra, M; Kuijpers, SA; van Seters, SP; Storm, G; Schiffelers, RM,期刊：Current Pharmaceutical Design, 页码：1825-1843 , 文章类型： Review，,卷期：2009年15-16]
Inflammation is considered a hallmark of cancer. The chronic inflammatory process is driven by the interaction of cells, proteins, cytokines, transcription factors, and lipid mediators within the tumor microenvironmen...
- Mast Cells as Target in Cancer Therapy
[作者：Kormelink, TG; Abudukelimu, A; Redegeld, FA,期刊：Current Pharmaceutical Design, 页码：1868-1878 , 文章类型： Review，,卷期：2009年15-16]
- A close interaction of cancer cells with their microenvironment is important for their growth and survival. In this respect, the involvement of inflammatory cells in the initiation, promotion and progression of cancer ha...
- Scientific and Clinical Challenges in Sepsis
[作者：Ulloa, L; Brunner, M; Ramos, L; Deitch, EA,期刊：Current Pharmaceutical Design, 页码：1918-1935 , 文章类型： Review，,卷期：2009年15-16]
- Advances in intensive care and antibiotics have prevented the spread of some infections, though sepsis mortality rates remain high. With failure of over thirty clinical trials, sepsis remains a scientific and clinical ch...
|